title: [Systemic mastocytosis without the typical mutation of codon 816 successfully treated with imatinib].
authors.affiliation: Department of Hematology and Oncology, Asahikawa Red Cross Hospital, Asahikawa .
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Hirayama
authors.forename: Yuich
authors.initials: Y
authors.lastname: Konuma
authors.forename: Kyuhei
authors.initials: K
authors.lastname: Kohda
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Ando
authors.forename: Masahiko
authors.initials: M
authors.lastname: Obata
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Ueno
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Sasagawa
authors.forename: Yuko
authors.initials: Y
authors.lastname: Wada
authors.forename: Sayaka
authors.initials: S
authors.lastname: Shirao
mesh_terms: D000368:Aged; D001549:Benzamides; D003062:Codon / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D034721:Mastocytosis, Systemic / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D003062:Codon; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit